4. AI in dentistry: ethical and regulatory considerations

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/7

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 7:59 PM on 9/3/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

8 Terms

1
New cards

AI can increase dentists’ diagnostic accuracy but may also (increase/decrease) invasive treatment decisions

Mertens et al, 2021

increase

2
New cards

what are some ethical risks of AI in dentistry?

  • reading scans, tx planning tools, EHR - pt info

  • biases: AI models can learn and amplify biases

  • impacts: group representation may see worse outcomes ot degraded accuracy (subgroup disparities)


3
New cards

the ethical risk of impact in terms of group representation is especially important for which models?

ML (still present in transformer-based generative AI models including LLMs)

4
New cards

what are some issues with transparency and over-reliance in AI in dentistry?

  • limited explainability: predictions w/o meaningful explanation, no reason

  • risk of over-reliance: decision SUPPORT

  • automation bias: AI output can influence clinical decisions even when the output is incomplete or incorrect

  • suggestion: treat it as a piece of evidence requiring professional review, not a true diagnosis


5
New cards

how can AI be used in dental practice?

  • diagnostic and clinical workflow - image, pathology detection, tx recs; FDA reg, etc

  • documentation workflows - summarize, scheduling, coding, automation


6
New cards

“no name” does not mean de-identified

HIPAA:

  • Safe Harbor (removing 18 specific identifiers)

  • Expert Determination (person with appropriate knowledge and experience certified re-ID risk is sufficiently small)


7
New cards

how to evaluate AI workfow?

  • regulatory and institutional approval

  • data classification and privacy

  • security and data handling

  • ethical review


8
New cards

summarize the key takeaways of this lecture:

  • AI can improve care, but it also introduces ethical, privacy, and regulatory risks

  • "No name" does not mean de-identified. FDA, HIPAA, institutional policy, and DUA rules may overlap

  • Evaluate risk across an entire process, not just a software or tool

  • AI supports clinical judgment; it does not replace it. We remain responsible for patient care decisions and patient data.